Board meeting set for November 3 financial results

Board & Shareholder Meetings View source PDF Explain this filing

AMANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹163.50

prior close

₹162.10

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+0.2% vs market

Pharmaceuticals peers, median of 174sector+1.2%-0.6% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.9

10m

+0.9

15m

+0.3

30m

+1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6+0.4+0.2+1.2-0.6

Next day

-2.8pendingpending+3.1-5.9

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Amanta Healthcare will meet on November 3, 2026 to approve unaudited financial results for the quarter and half year ended September 30, 2026. The trading window, closed since October 1, will reopen on November 6.

Likely market impact

Results may affect the stock after the November 3 announcement. Trading resumes on November 6 once the results are public.